Company Filing History:
Years Active: 2012
Title: Edwin Curran Murphy, III: Innovator in Injectable Meclizine Formulations
Introduction
Edwin Curran Murphy, III is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable formulations for treating conditions such as vertigo, nausea, and vomiting. With a total of two patents to his name, Murphy's work is paving the way for advancements in medical treatments.
Latest Patents
Murphy's latest patents focus on injectable meclizine formulations and methods. These patents disclose methods for treating or preventing vertigo, nausea, or vomiting by injecting a subject with a pharmaceutically acceptable formulation. This formulation consists of an effective amount of meclizine or a pharmaceutically acceptable salt thereof, a chemically modified cyclodextrin, and an aqueous carrier medium with a pH between about 2 and about 7. The injectable pharmaceutical formulation aims to provide effective treatment options for patients suffering from these conditions.
Career Highlights
Murphy is currently associated with Genebiology, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving patient outcomes through advanced drug formulations.
Collaborations
Some of Murphy's notable coworkers include Walker A Long and Walker Anderson Long. Their collaborative efforts contribute to the innovative environment at Genebiology, Inc.
Conclusion
Edwin Curran Murphy, III is a distinguished inventor whose work in injectable meclizine formulations is making a significant impact in the medical field. His contributions are essential for the development of effective treatments for vertigo, nausea, and vomiting.